By_IN assaying_VBG CAT_NN enzyme_NN activity_NN across_IN a_DT 24-h_JJ PRL_NN induction_NN time_NN course_NN ,_, we_PRP were_VBD able_JJ to_TO assign_VB G1_NN vs._CC S_NN phase_NN PRL_NN responses_NNS of_IN the_DT IRF-1_NN gene_NN to_TO different_JJ regions_NNS of_IN the_DT IRF-1_NN and_CC promoter_NN DNA_NN ._.
This_DT was_VBD accompanied_VBN by_IN downregulation_NN of_IN two_CD transcription_NN factors_NNS normally_RB expressed_VBN in_IN erythroid_JJ ,_, mast_NN and_CC megakaryocyte_NN lineages_NNS ._.
Furthermore_RB ,_, p50_NN protein_NN was_VBD detected_VBN in_IN the_DT cytoplasm_NN of_IN all_DT lymphocytes_NNS ._.
To_TO define_VB the_DT mechanism_NN underlying_VBG signal_NN transducer_NN and_CC activator_NN of_IN transcription_NN STAT_NN protein_NN recruitment_NN to_TO the_DT interleukin_NN 10_CD IL-10_NN receptor_NN ,_, the_DT STAT_NN proteins_NNS activated_VBN by_IN IL-10_NN in_IN different_JJ cell_NN populations_NNS were_VBD first_RB defined_VBN using_VBG electrophoretic_JJ mobility_NN shift_NN assays_NNS ._.
However_RB ,_, upon_IN transition_NN from_IN a_DT proliferating_JJ G1_NN to_TO a_DT resting_JJ state_NN of_IN the_DT cell_NN cycle_NN the_DT three_CD genes_NNS were_VBD differently_RB regulated_VBN ._.
A_DT PMA_NN responsive_JJ element_NN was_VBD localized_JJ to_TO a_DT region_NN between_IN -95_CD and_CC -36_CD bp_NN relative_JJ to_TO the_DT transcription_NN start_NN site_NN ._.
Nuclear_JJ factor-kappa_NN B_NN NF-kappa_NN B_NN is_VBZ a_DT transcription_NN factor_NN that_WDT binds_VBZ to_TO the_DT consensus_NN DNA_NN sequence_NN in_IN the_DT cis-acting_JJ elements_NNS of_IN various_JJ genes_NNS ._.
Activation_NN of_IN protein_NN kinase_NN C_NN and_CC elevation_NN of_IN cAMP_NN interact_VBP synergistically_RB to_TO raise_VB c-Fos_NN and_CC AP-1_NN activity_NN in_IN Jurkat_NN cells_NNS ._.
The_DT effect_NN of_IN transmembrane_NN signaling_NN of_IN T_NN cells_NNS with_IN ionomycin_NN ,_, sn-1,2_NN dioctanoyl_NN glycerol_NN ,_, was_VBD also_RB determined_VBN ._.
Dimerization_NN among_IN transcription_NN factors_NNS has_VBZ become_VBN a_DT recurrent_JJ theme_NN in_IN the_DT regulation_NN of_IN eukaryotic_JJ gene_NN expression_NN ._.
The_DT bcl-2_NN gene_NN ,_, a_DT repressor_NN of_IN lymphocyte_NN death_NN ,_, is_VBZ perhaps_RB the_DT best_JJS understood_VBN of_IN the_DT programmed_VBN cell_NN death_NN associated_JJ genes_NNS ._.
In_IN addition_NN to_TO NB4_NN cells_NNS ,_, ATRA_NN also_RB activated_VBD IRF-1_NN gene_NN expression_NN in_IN HL-60_NN ,_, U937_NN ,_, and_CC THP-1_NN cells_NNS ,_, which_WDT all_DT respond_VBP to_TO ATRA_NN by_IN growth_NN inhibition_NN ._.
In_IN agreement_NN with_IN this_DT finding_NN ,_, Northern_NN experiments_NNS where_WRB p65_NN and_CC p105_NN mRNA_NN levels_NNS were_VBD determined_VBN ,_, demonstrated_VBD that_IN expression_NN of_IN these_DT components_NNS of_IN the_DT NF-kappa_NN B_NN transcription_NN factor_NN were_VBD not_RB affected_VBN by_IN IL-10_NN or_CC IL-4_NN ._.
n-Acetyl-L-cysteine_NN NAC_NN ,_, a_DT potent_JJ antioxidant_NN ,_, blocked_VBD NF-kappa_NN B_NN activation_NN caused_VBN by_IN IL-4_NN and_CC by_IN anti-CD40_JJ mAb_NN ._.
Western_NN blot_NN with_IN an_DT N-terminal_JJ antibody_NN showed_VBD normal_JJ levels_NNS of_IN immunoreactive_JJ GR_NN ,_, but_CC quantitative_JJ analysis_NN with_IN isoform-specific_JJ C-terminal_JJ antibodies_NNS revealed_VBD a_DT markedly_RB reduced_VBN GRalpha_NN expression_NN ,_, and_CC high_JJ GRbeta_NN expression_NN ._.
A_DT lymphoid-specific_JJ element_NN ,_, microB_NN ,_, is_VBZ necessary_JJ for_IN enhancer_NN function_NN in_IN pre-B_JJ cells_NNS ._.
IL-4_NN secreted_VBN by_IN activated_VBN T_NN cells_NNS is_VBZ a_DT pleiotropic_JJ cytokine_NN affecting_VBG growth_NN and_CC differentiation_NN of_IN diverse_JJ cell_NN types_NNS such_JJ as_IN T_NN cells_NNS ,_, B_NN cells_NNS ,_, and_CC mast_NN cells_NNS ._.
These_DT studies_NNS demonstrate_VBP that_IN CMV_NN may_MD be_VB an_DT important_JJ cofactor_NN in_IN the_DT development_NN of_IN rejection_NN and_CC infection_NN after_IN transplantation_NN through_IN effects_NNS on_IN IL-6_NN ._.
Studies_NNS of_IN the_DT actions_NNS of_IN platelet-activating_JJ factor_NN have_VBP centered_VBN mainly_RB around_IN neutrophils_NNS ,_, monocytes_NNS ,_, and_CC platelets_NNS ._.
In_IN this_DT report_NN ,_, we_PRP show_VBP that_IN upon_IN the_DT stimulation_NN of_IN both_DT pathways_NNS T_NN lymphocytes_NNS became_VBD refractory_JJ to_TO activation_NN via_IN the_DT cell_NN receptor_NN TcR_NN complex_NN ._.
The_DT long_JJ terminal_JJ repeat_NN LTR_NN of_IN the_DT type_NN 1_CD human_JJ immunodeficiency_NN virus_NN HIV-1_NN and_CC the_DT regulatory_JJ region_NN of_IN the_DT gene_NN encoding_VBG the_DT interleukin_NN 2_CD receptor_NN alpha_NN subunit_NN IL-2R_NN alpha_NN share_NN functional_JJ kappa_NN B_NN enhancer_NN elements_NNS involved_VBN in_IN the_DT regulation_NN of_IN these_DT inducible_JJ transcription_NN units_NNS during_IN T-cell_NN activation_NN ._.
Immune_JJ response_NN of_IN peripheral_JJ blood_NN mononuclear_JJ cells_NNS to_TO HBx-antigen_NN of_IN hepatitis_NN B_NN virus_NN ._.
The_DT transcriptionally_RB active_JJ factors_NNS mediating_VBG the_DT effect_NN of_IN the_DT HTLV-I_NN Tax_NN transactivator_NN on_IN the_DT IL-2R_NN alpha_NN kappa_NN B_NN enhancer_NN include_VBP the_DT product_NN of_IN the_DT c-rel_NN proto-oncogene_NN ._.
One_CD clone_NN DEG5_NN also_RB exerted_VBD a_DT high_JJ and_CC specific_JJ cytotoxicity_NN against_IN autologous_JJ cells_NNS pulsed_VBN with_IN ._.
In_FW vitro_FW transcription_NN and_CC translation_NN of_IN the_DT complementary_JJ DNA_NN resulted_VBD in_IN the_DT synthesis_NN of_IN a_DT protein_NN with_IN an_DT apparent_JJ molecular_JJ size_NN of_IN 65_CD kilodaltons_NNS kD_NN ._.